4553.T
4553.T
JP3623150004
TOWA PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 273.710.000.000 259.594.000.000
5.4%
Cost of Revenue 174.606.000.000 164.865.000.000
5.9%
Gross Profit 99.104.000.000 94.729.000.000
4.6%
76.001.000.000 71.486.000.000
6.3%
Operating Income 23.103.000.000 23.243.000.000
0.6%
Pretax Income 13.165.000.000 26.330.000.000
50.0%
Net Income Common Stockholders 5.250.000.000 18.986.000.000
72.3%
-- --
--
-- --
--
ende